Japanese waxtree

Japanese Waxtree (Toxicodendron succedaneum / Rhus succedanea)

1. Identity: Botanical Classification, Names, and Natural Source

Toxicodendron succedaneum (L.) Kuntze, belonging to the family Anacardiaceae, is a deciduous tree widely distributed in South and Southeast Asia. It is known by several common names: the wax tree, the Japanese Hazenoki tree, sơn in Vietnamese, and charão in Portuguese. The accepted current scientific name is Toxicodendron succedaneum (L.) Kuntze, while its long-used botanical synonym — still widely encountered in phytochemical literature — is Rhus succedanea L. The two names refer to the same taxon: Toxicodendron succedaneum (L.) Kuntze is the accepted designation, with Rhus succedanea L. as its synonym.

The genus name Toxicodendron derives from Greek, meaning "poison tree." The specific epithet succedaneum refers to its wax-like secretions, which were utilized historically as a substitute for other materials, such as beeswax, in various applications.

There has been considerable uncertainty amongst botanists as to the best way of treating the genus Toxicodendron, with some viewing it as a genus distinct from Rhus, whilst others lump the two genera together. One of the major differences from a gardener's viewpoint is that Toxicodendron has a toxic sap and fruits with a thick, waxy mesocarp.

The plant is native to Eastern Asia and is found in India, China, Bangladesh, Thailand, Vietnam, Japan, Nepal, Bhutan, Laos, Myanmar, Korea, Oceania, and Pakistan. Within its native range, it grows in forests and shrubberies at elevations up to 2,400 metres in the Himalayas.

Morphology

It is a large shrub or tree, up to 8 m tall, somewhat similar to a sumac tree. The Japanese waxtree is a deciduous tree that can grow between 10 to 15 meters tall. Its leaves are alternating and compound, typically comprising 5 to 7 leaflets that exhibit a glossy green hue. In the autumn months, these leaves transform into striking shades of yellow and red, providing a stunning display. It is one of the city tree symbols of Kurume, Fukuoka, Japan.

Common Preparations and Forms

• Japan wax (fruit wax): In East Asia, particularly in Japan, traditional candle fuel — also called Japan wax — was produced from the crushed fruits of T. succedaneum rather than beeswax or animal fats. Japan wax is a byproduct of lacquer manufacture and is not a true wax, but a fat that contains 10–15% palmitin, stearin, and olein with about 1% japanic acid (1,21-heneicosanedioic acid). Japan wax is sold in flat squares or disks and has a rancid odor. It is extracted by expression, heat, or the action of solvents.
• Lacquer/resin: The lacquer obtained from lacquer trees — the sap obtained by tapping — has been used as a coating and painting material for a long time in China, Japan, Thailand, Vietnam, and the Korean Peninsula, valued for its water resistance, antioxidant, and corrosion resistance properties. In Vietnam, lacquer is used to produce lacquer paintings known as sơn mài from the resin of the tree.
• Fruit wax (cosmetic grade): In cosmetics, the fruit wax — known as Rhus Succedanea Fruit Cera (Japan Wax) — is commonly used as a plant-based alternative to beeswax and synthetic waxes. It is rich in various fatty acids, glycerides, esters, and phytosterols that give the ingredient its emollient and film-forming properties.
• Plant-part extracts (medicinal): Historically, the bark, leaves, and especially the fruits of the Japanese waxtree have been valued for their medicinal properties. In research settings, extracts from leaves, seed kernels, drupes, and stem bark have been prepared in ethanol, methanol, or water.
• Fisetin (isolated compound): The stems of T. succedaneum are also a commercial source of fisetin, extracted in China.

2. Traditional and Historical Use

East Asia: Japan, China, Korea, and Vietnam

The Japanese waxtree (Rhus succedanea) has a long history of use in traditional East Asian medicine, particularly in Japan and China. It is a plant of significant historical and cultural importance, particularly in Asian lacquer production. It is one of the primary species of Toxicodendron that is harvested on a commercial basis for its sap, which is used to make a varnish that is widely employed in Oriental artwork.

In Asia, T. succedaneum is cultivated for its fruits, from which a wax is extracted. Wax obtained from the fruit is used to make candles, floor wax, varnishes, polishes, ointments, and plasters. The wax is also used in traditional Asian medicine.

Traditionally, extracts from the fruit and leaves were utilized for their purported anti-inflammatory, analgesic, and antioxidant properties. The plant was also valued for its wax, historically used in candle making and as a protective coating.

In the Shingon sect of esoteric Buddhism in Japan, this tree is used to make a fire offering called goma.

South Asia: India, Nepal, and Bangladesh

The plant is used as a medicinal plant in India. Traditional systems of medicine have used Rhus succedanea L. to treat a variety of ailments like infections, dysentery, nose and gum bleeding, cough, tuberculosis, fever, and asthma.

T. succedaneum has been used to treat diarrhea, nose and gum bleedings, vomiting, dysentery, cough, tuberculosis, fever, asthma, liver ailments, and ear infections in traditional medicines.

Vietnam

The plant is used to produce lacquer; in Vietnam, lacquer is used to produce paintings known as sơn mài from the resin of the tree. Traditional medicinal use of the plant's bark and resin for dermatological purposes has also been documented in this region.

Wounds and Skin Ailments

The Japanese waxtree has been used in traditional East Asian medicine for the treatment of wounds and sores. Historical texts from Chinese and Japanese herbal medicine mention the application of its extracts, particularly the wax and resin, for their purported healing and protective properties on the skin. These traditional uses are largely based on empirical knowledge passed down through generations rather than modern scientific validation.

3. Key Chemical Constituents and Active Compounds

Major bioactive compounds reported in the plant are urushiols, bichalcones, biflavonoids such as succedaneaflavanone, agathisflavone, rhusflavanone, amentoflavone, cupressuflavone, robustaflavone, volkensiflavone, morelloflavone, and hinokiflavone.

Biflavonoids, urushiols, and bi-chalcones are abundant in the genus Rhus succedanea. Alkaloids, flavonoids, terpenoids, saponins, carbohydrates, proteins, phenols, amino acids, and anthraquinones were also found to be present in the leaf extract.

Urushiols

Like other members of the Toxicodendron genus, T. succedaneum contains urushiol, a toxic oil that can cause skin irritation and allergic reactions upon contact. Urushiol is the same compound found in poison ivy and poison oak. Urushiol is a mixture of 3-n-pentadecylcatechols, which contain a catechol ring moiety substituted with different aliphatic chains. Urushiol is fat-soluble, penetrating the stratum corneum of the skin, then binding to Langerhans cells in the epidermis. The affected cells then migrate to lymph nodes, where T cells become activated, then return to the skin where they stimulate an urushiol-activated dermatitis.

Biflavonoids

Several biflavonoids have been isolated from various parts of T. succedanea, possessing a wide range of pharmacological activities, especially potential antiviral properties. The biflavonoids including agathisflavone, hinokiflavone, amentoflavone, robustaflavone, rhusflavanone, and succedaneaflavanone were isolated from the seed kernels of T. succedanea with noticeable antiviral activity.

Hinokiflavone

The plant produces hinokiflavone, a cytotoxic biflavonoid. Research into its structural requirements showed that hinokiflavone was isolated as the cytotoxic principle from the drupes of Rhus succedanea L. A comparison of the cytotoxicity of hinokiflavone and other related biflavonoids indicates that an ether linkage between two units of apigenin is structurally required for significant cytotoxicity.

Fisetin

The stems of T. succedaneum are also a commercial source of fisetin, extracted in China. Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a naturally occurring flavonol. It exhibits diverse biological activities, including anti-inflammatory, antioxidant, senolytic, and lipid-lowering properties. Fisetin modulates several key signaling pathways, including NF-κB, Nrf2, AMPK, and SIRT1, leading to reduced inflammatory cytokine expression, enhanced antioxidant defenses, and improved lipid homeostasis.

Japan Wax Lipid Composition

The main constituents of Japan wax are glyceryl palmitate and esters of japonic acid (heneicosanedioic acid, C21H40O4), phellogenic acid (docosanedioic acid, C22H42O4), and tricosanedioic acid (C23H44O4). It is rich in various fatty acids, glycerides, esters, and phytosterols that give the ingredient its emollient and film-forming properties.

Additional Constituents

Phytochemical screening of the leaf shows the presence of carbohydrates, protein, alkaloids, phenols, flavonoids, terpenoids, and anthraquinones. Quantitatively, the highest amounts detected were alkaloids (16%) and flavonoids (19%) in the leaf.

Mechanisms of Action

Fisetin from Rhus succedanea is an orally bioavailable polyphenol with potential antioxidant, neuroprotective, anti-inflammatory, antineoplastic, senolytic, and longevity-promoting activities. Upon administration, fisetin scavenges free radicals, protects cells from oxidative stress, and can upregulate glutathione. It inhibits proinflammatory mediators such as tumor necrosis factor-alpha (TNF-α), interleukin-6, and NF-κβ.

Fisetin's antioxidant effects arise from direct radical-scavenging activity mediated by hydroxyl groups on the flavone backbone, as well as indirect antioxidant responses through activation of the Nrf2 pathway. Its anti-inflammatory properties are driven mainly by suppression of NF-κB signaling.

4. Scientific Evidence by Area of Use

It is critical to note at the outset that few studies have explored the antiviral effect of isolated phytochemicals like hinokiflavone, robustaflavone, biflavonoid, amentoflavone, and agathisflavone on several viruses like HSV, HIV, and HBV. Unfortunately, most research on the plant appears to be only partial, consisting of in-vitro studies with a lack of experimental and clinical trials. The available literature on T. succedaneum suggests insufficient data on pharmacological studies in experimental animals.

4.1 Antiviral Activity

In-vitro biflavonoids from T. succedaneum exhibited a strong antiviral effect by inhibiting the replication of HIV, HBV, and HSV.

To the best of available knowledge, only one study examined the broad-spectrum antiviral properties of sumac extracts, and that work focused on biflavonoids isolated from the seed kernels of R. succedanea. Six biflavonoids — robustaflavone, amentoflavone, agathisflavone, volkensiflavone, succedaneaflavanone, and rhusflavanone — were isolated from R. succedanea seeds and tested for inhibitory activities against a number of viruses including respiratory viruses (influenza A, influenza B, respiratory syncytial, parainfluenza type 3, adenovirus type 5, and measles) and herpes viruses (HSV-1, HSV-2, HCM, and VZV).

Robustaflavone exhibited a strong antiherpes (HSV-1 and HSV-2) and anti-influenza A activity against the strains H1N1 and H3N2 with the EC50 of 1.9 and 4.1 μg/mL, respectively. Amentoflavone exhibited potential antiviral activity against both influenza virus strains with the EC50 of 3.1 and 4.3 μg/mL, respectively.

Evidence strength: These are in-vitro results only. No human or animal clinical trials on T. succedaneum-derived biflavonoids as antiviral agents have been published. Evidence is preliminary and insufficient to support clinical use.

4.2 Anticancer / Cytotoxic Activity

R. succedanea extract inhibited the growth of DU145, PC-3, H1975, HCT116, and A375 cancer cells with IC50 concentrations of 24.5, 11.04, 7.71, 8.87, and 13.13 µg/mL respectively. Two new antioxidative and cytotoxic compounds, 10′(Z),13′(E),15′(E)-heptadecatrienyl hydroquinone and 10′(Z),13′(E)-heptadecatrienyl hydroquinone, as well as the known 10′(Z)-heptadecenylhydroquinone, were isolated from an ethanol extract of the sap of R. succedanea and exhibited antioxidative and cytotoxic activities against five cancer cell lines.

More recently, Toxicodendron succedaneum, a medicinally important plant from the family Anacardiaceae, contains diverse phytoconstituents with potential anticancer activity. An in silico investigation examined its phytochemicals as extracellular signal-regulated kinase 2 (ERK2) inhibitors for non-small cell lung cancer therapy using molecular dynamics simulation and quantum mechanics approaches.

With respect to the cytotoxic biflavonoid hinokiflavone, structural analysis demonstrated that an ether linkage between two units of apigenin is structurally required for significant cytotoxicity, and certain methylated derivatives also demonstrated significant cytotoxicity.

Approximately 238 compounds — mainly phenolic acids and their derivatives, urushiols, flavonoids, and terpenoids — have been extracted and isolated from Toxicodendron plants, with T. succedaneum being among the most studied.

Evidence strength: All anticancer evidence is in-vitro and in-silico (computational). No animal or human studies have assessed anticancer efficacy of whole-plant extracts or isolated compounds from T. succedaneum. Evidence is preclinical and preliminary only.

4.3 Anti-inflammatory Activity

Plants from the Rhus genus are renowned for their medicinal properties, including anti-inflammatory effects. A systematic review conducted following PRISMA guidelines evaluated the anti-inflammatory effects of Rhus plants and explored their potential pharmacological mechanisms, with a total of 35 articles included. Rhus succedanea was among the species analyzed. In vitro studies consistently demonstrated the ability of Rhus plants to reduce key inflammatory mediators such as TNF-α, IL-1β, and IL-6. In vivo studies confirmed these effects in murine models of inflammation, with doses mostly of 400 and 800 mg/kg body weight, with no reports of toxicity.

Evidence strength: Anti-inflammatory activity is established in cell-culture and animal models. The systematic review included Rhus succedanea among multiple species. No clinical trials in human subjects specifically addressing T. succedaneum as an anti-inflammatory agent have been identified.

4.4 Antioxidant Activity

Laboratory studies have identified several bioactive compounds within the tree, including flavonoids and polyphenols, which are known for their antioxidant activity. Preliminary in vitro and animal studies suggest that extracts from the Japanese waxtree may help reduce oxidative stress and inhibit certain inflammatory pathways.

In-vitro studies have demonstrated the antioxidant, antibacterial, antitumor, and antileukemic activities of T. succedaneum, supporting the rationale behind its traditional use.

Evidence strength: Antioxidant data are from in-vitro assays (DPPH scavenging, FRAP, etc.) and preliminary animal studies. No controlled human trials exist.

4.5 Fisetin: A Commercially Sourced Compound (Gulf War Illness Clinical Trial)

Fisetin, commercially sourced from Rhus succedanea stems, has been tested in a notable human clinical study. Resveratrol, luteolin, and fisetin (from Rhus succedanea) were tested on symptom severity of Gulf War Illness (GWI) in a placebo-controlled, pseudo-randomized, crossover clinical trial. Twenty-one male veterans with GWI completed the study protocol, which consisted of one month of baseline symptom reports, one month of placebo, one month of lower-dose botanical, and one month of higher-dose botanical.

Fisetin exhibits robust antioxidant and anti-inflammatory activities and has notable anticancer and neuroprotective effects. It strongly modulates key cellular signaling pathways, induces apoptosis, and inhibits tumor growth, thus protecting cells against oxidative damage and neurodegenerative events. Additional hepatoprotective, antiviral, and gastroprotective actions further highlight the therapeutic importance of this compound.

Recent reviews and experimental studies have demonstrated that fisetin improves insulin sensitivity, reduces hepatic lipid accumulation, modulates redox signaling, and attenuates inflammatory responses in metabolic liver disorders. These findings strengthen the rationale for investigating fisetin as a therapeutic candidate in liver diseases with inflammatory and metabolic components.

Evidence strength: The GWI crossover trial is the most relevant human evidence directly linking commercially sourced fisetin from Rhus succedanea to clinical outcomes. However, the study population was small (21 veterans), the design was a crossover without a true parallel control arm for all arms, and results relate to the isolated compound fisetin rather than to whole-plant extracts of T. succedaneum. The broader fisetin research base (applicable because the compound is the same regardless of botanical source) is substantial in preclinical and in-vitro terms, with ongoing clinical trials, but most human evidence remains early-stage.

4.6 Antidiabetic Activity

The anti-inflammatory, anti-diabetic, antioxidant, antibacterial, anticancer, antileukemic, and antiviral properties of Rhus succedanea L. have been revealed using various parts of the plant, proving the validity of its traditional use. Antidiabetic activity is attributed in part to fisetin and the biflavonoid constituents, but most research on the plant appears to consist only of in-vitro studies, with a lack of experimental and clinical trials.

Evidence strength: Antidiabetic claims rest on in-vitro data only; no controlled human studies are available for T. succedaneum preparations as antidiabetic agents.

4.7 Antimicrobial Activity

In-vitro studies have demonstrated the antioxidant, antibacterial, antitumor, and antileukemic activities of T. succedaneum. The antibacterial activity has been linked to urushiol analogs and to the tannin content of the plant. Pharmacological studies conducted on Rhus succedanea indicate the plant's potential in the treatment of various conditions such as cancer, hepatitis, inflammation, and bacterial and viral infections.

Evidence strength: In-vitro only. No clinical antimicrobial studies exist.

4.8 SARS-CoV-2 (Computational Study)

A computational (molecular docking and molecular dynamics) study found that biflavonoids from Rhus succedanea can be utilized as promising SARS-CoV-2 Mpro inhibitors, with findings providing an initial footstep towards experimental studies in in vitro and in vivo, which is necessary for the therapeutic development of novel and safe drugs to control SARS-CoV-2. Molecular interactions and molecular dynamics displayed that all six biflavonoids bound with good affinity to the same catalytic site of Mpro. Amentoflavone was found to have a strong binding affinity (−27.0441 kcal/mol) towards Mpro.

Evidence strength: Purely computational (in silico). No in-vitro, in-vivo, or clinical data corroborate these findings for T. succedaneum against SARS-CoV-2.

5. Body Systems and Health Areas Associated with Japanese Waxtree

• Integumentary (skin) system: Traditional use for wounds, sores, and dermatological conditions including scabies and skin infections. The Japan wax is used in cosmetic emollients. The urushiol content also makes the plant itself a major cause of allergic contact dermatitis.
• Respiratory system: The plant treats asthma, cough, and pulmonary infections in traditional use.
• Gastrointestinal system: Traditional use includes treating diarrhea, vomiting, and dysentery.
• Hepatic (liver) system: Some research has explored its potential antimicrobial and hepatoprotective effects, indicating a promising role in supporting liver health. Fisetin, sourced from the stems, has been studied in hepatoprotective contexts.
• Immune / antiviral system: Biflavonoids have been tested in vitro against HIV, HBV, HSV, and influenza viruses.
• Oncology / cellular systems: In-vitro and computational studies have explored cytotoxic and antiproliferative activity against multiple cancer cell lines.
• Metabolic / endocrine system: Fisetin from the stems has been associated in preclinical research with improved insulin sensitivity and glucose metabolism.
• Nervous system: Fisetin has documented neuroprotective activities in preclinical models, and was explored clinically in veterans with Gulf War Illness.

6. Dosage Forms and Dosages Reported in Studies

No standardized therapeutic dosages for whole-plant extracts of Toxicodendron succedaneum have been established by any regulatory body or pharmacopeia. The following dosages are reported solely as stated in the cited research:

• In-vitro antiviral (biflavonoids from seed kernels): Robustaflavone showed anti-influenza activity at EC50 values of 1.9 µg/mL (H1N1) and 4.1 µg/mL (H3N2); amentoflavone showed antiviral activity against both influenza strains at EC50 of 3.1 and 4.3 µg/mL, respectively.
• In-vitro anticancer (whole-plant extract): R. succedanea extract inhibited the growth of DU145, PC-3, H1975, HCT116, and A375 cancer cells with IC50 concentrations of 24.5, 11.04, 7.71, 8.87, and 13.13 µg/mL respectively.
• In-vivo (animal) anti-inflammatory (Rhus genus): In vivo studies in murine models of inflammation used doses mostly of 400 and 800 mg/kg body weight, with no reports of toxicity.
• Japan wax (cosmetic): Used at functional levels in formulations such as lipsticks, balms, creams, and lotions; no specific medicinal dosage established.
• Fisetin (clinical trial, Gulf War Illness): Fisetin sourced from Rhus succedanea was tested in a crossover clinical trial with a lower-dose phase and a higher-dose phase, each lasting one month, in 21 male veterans with Gulf War Illness. The specific dose amounts were not publicly available in the search results reviewed.

7. Safety Considerations and Known Interactions

Urushiol-Induced Contact Dermatitis

The resin produced in T. succedaneum is used in decorating traditional handicrafts, but the resinous latex is poisonous and causes severe dermatitis problems in more sensitized persons.

Urushiol causes an eczematous contact dermatitis characterized by redness, swelling, papules, vesicles, blisters, and streaking. People vary greatly in their sensitivity to urushiol. In approximately 15% to 30% of people, urushiol does not trigger an immune system response, while at least 25% of people have a very strong immune response resulting in severe symptoms. The rash takes one to two weeks to run its course and may cause scars, depending on the severity of the exposure.

One in four people is likely to experience severe symptoms. Since the skin reaction is an allergic one, people may develop progressively stronger reactions after repeated exposures.

As little as 0.001 mg of urushiol is enough to cause allergic contact dermatitis. Symptoms of allergic contact dermatitis from urushiol exposure vary from a mild annoyance to weeks of irritation and pain. Occasionally, exposure can lead to nephropathy and even to fatal systemic anaphylaxis.

A specific clinical report of T. succedaneum contact dermatitis in New Zealand documented a seasonal pattern: Rademaker and Duffill published a case series entitled "Allergic contact dermatitis to Toxicodendron succedaneum (rhus tree): an autumn epidemic," published in the New Zealand Medical Journal (1995 Apr 12;108(997):121–3).

Japan Wax Occupational Safety

The leaves, fruit, and bark of Rhus succedanea can cause dermatitis. The wax has caused dermatitis in workers handling fabrics waterproofed with it. Rhus succedaneum is a well-known sensitizing shrub in Japan.

Cross-Reactivity

Urushiol or related chemicals are also found in the Anacardiaceae group, which includes, among others, the lacquer tree of Asia, the mango tree, cashew shell oil, and certain nut shells such as the walnut. Cross-reactivity between T. succedaneum and related plants carrying urushiol must therefore be considered in sensitized individuals.

Systemic Contact Dermatitis from Ingestion

A popular food in Korea called "Rhus chicken," which consists of roasted chicken covered in a Rhus (urushiol) coating, is commonly ingested for therapeutic purposes for gastrointestinal issues, and several cases of systemic contact dermatitis (SCD) in response to Rhus chicken have been reported. The most common manifestation of SCD due to ingestion of Rhus chicken is an erythematous maculopapular rash on the trunk and extremities.

Regulatory and Invasive Species Status

Because of its beautiful autumn foliage, T. succedaneum has been planted outside Asia as an ornamental plant, often by gardeners who were apparently unaware of the dangers of allergic reactions. It is now officially classified as a noxious weed in Australia and New Zealand.

Overall Toxicological Profile of the Plant

Despite numerous medical benefits demonstrated by researchers, different plant parts are extremely poisonous and can cause adverse reactions when consumed. With the presence of hinokiflavone and the skin-irritating oil urushiol, the plant causes severe allergies in humans, which urges standardization of the effectiveness of this species.

The available literature on T. succedaneum suggests insufficient data on pharmacological studies in experimental animals, and much research needs to be done to confirm its folk medicinal uses for developing phytopharmaceutical drugs.

The isolated compound fisetin (sourced from the stems) has a distinct and more favorable safety profile compared to whole-plant extracts containing urushiol. Toxicological profiling of fisetin includes safety concerns such as genotoxicity at higher concentrations.

8. Summary of Evidence Quality

Across all areas of proposed medicinal use, evidence for Toxicodendron succedaneum / Rhus succedanea as a therapeutic agent remains predominantly preclinical. In-vitro studies have demonstrated the antioxidant, antibacterial, antitumor, and antileukemic activities of T. succedaneum, supporting the rationale behind its traditional use, yet much research needs to be done to confirm its folk medicinal uses for developing phytopharmaceutical drugs. Extensive literature surveys through Web of Science, Scopus, ScienceDirect, and PubMed have found that the currently accessible literature on Rhus succedanea L. indicates a lack of compiled information on pharmacological research conducted. No randomized controlled clinical trials examining whole-plant extracts of T. succedaneum in human subjects have been identified. The compound fisetin, when commercially extracted from the stems, has the most developed clinical evidence base, but this evidence pertains to fisetin itself rather than to preparations of the waxtree as such.

References

• Gurav et al. (2022). Toxicodendron succedaneum (L.) Kuntze (Japanese wax tree): A review on its phytochemistry, pharmacology, and toxicity. ResearchGate / Pharmaceutical Sciences Asia.
• Gurav et al. (2022). Toxicodendron succedaneum (L.) Kuntze (Japanese wax tree): A review on its phytochemistry, pharmacology, and toxicity. Pharmaceutical Sciences Asia 49(5), 425–434. Semantic Scholar PDF.
• IJPRAS. Review Article: Rhus succedanea Linn — An Update of Its Indigenous Uses, Phytochemistry, and Pharmacology.
• IJBPAS (2025). Rhus succedanea Linn: Phytochemistry and Pharmacology Update.
• Bioactivities of Toxicodendron succedaneum (L.) Kuntze extracts and isolated compounds. ResearchGate.
• Gopalakrishna SM et al. (2014). In vitro anticancer activity of Solanum indicum, Rhus succedanea, Rheum emodi and Gardenia gummifera in cancer cells. ResearchGate.
• A comprehensive review of medicinal Toxicodendron (Anacardiaceae): Botany, traditional uses, phytochemistry and pharmacology. ResearchGate (2023).
• Nath et al. (2025). In silico investigation of Toxicodendron succedaneum phytochemicals as ERK2 inhibitors for non-small cell lung cancer therapy. PubMed.
• Toxicodendron succedaneum. Wikipedia.
• Biology: Toxicodendron succedaneum. HandWiki.
• Toxicodendron succedaneum. ScientificLib.
• Biological Activities of Extracts from Sumac (Rhus spp.): A Review. Academia.edu.
• Urushiol — Overview. ScienceDirect Topics.
• Urushiol-induced contact dermatitis. Wikipedia.
• Urushiol Compounds Detected in Toxicodendron-Labeled Consumer Products Using Mass Spectrometry. PMC / NCBI.
• Toxicodendron Toxicity. StatPearls. NCBI Bookshelf / NIH.
• Rhus tree / Toxicodendron. DermNet NZ.
• Toxicodendron succedaneum. New Zealand Plant Conservation Network.
• Rademaker M, Duffill MB (1995). Toxicodendron succedaneum (Rhus tree), New Zealand's poison ivy. Contact Dermatitis. PubMed.
• Hodgin et al. (2021). A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Resveratrol, Luteolin, and Fisetin (Rhus succedanea). ResearchGate.
• Fisetin: a multitarget flavonol bridging oxidative stress, inflammation, aging, and cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. Springer (2025).
• Mechanistic Analysis of Fisetin in Liver Diseases and Its Potential Therapeutic Application in IFALD. PMC / NCBI.
• Fisetin as a multifunctional bioactive flavonoid: A comprehensive review. ScienceDirect (2025).
• Anti-inflammatory Potential of Plants of Genus Rhus. Thieme Connect (2025).
• Rhus Succedanea Fruit Cera: Cosmetic Ingredient INCI. SpecialChem.
• Rhus succedanea — Wax Tree. Plants for a Future (PFAF) Database.
• Toxicodendron succedaneum. Useful Tropical Plants Database.